Terutaka Hashizume

Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

T Kesado, Terutaka Hashizume, Y Asahi · Antimicrobial Agents and Chemotherapy · 1980 · 112 citations · Full text

New Stabilized Thienamycin, Health Sciences, Antibiotics +15

Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: Binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli.

Terutaka Hashizume, Fumitoshi Ishino, Junichi Nakagawa et al. · The Journal of Antibiotics · 1984 · 81 citations · Full text

Dicationic dithiocarbamate carbapenems with anti-MRSA activity

Hideaki Imamura, Norikazu Ohtake, Hideki Jona et al. · Bioorganic & Medicinal Chemistry · 2001 · 68 citations

Anti-mrsa Activity, Antibacterial Agent, Antimicrobial Compound +2

Carbapenem Derivatives as Potential Inhibitors of Various β-Lactamases, Including Class B Metallo-β-Lactamases

Rie Nagano, Yuka Adachi, Hideaki Imamura et al. · Antimicrobial Agents and Chemotherapy · 1999 · 68 citations · Full text

Antimicrobial Chemotherapy, Type Ii, Various β-Lactamases +19

Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus

R Nagano, Kenji Shibata, Toshio Naito et al. · Antimicrobial Agents and Chemotherapy · 1997 · 43 citations · Full text

Mrsa Septicemia Model, Novel Dithiocarbamate Carbapenem, Pharmacotherapy +20